The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prediction of pathological response to neo-adjuvant chemotherapy using texture parameters of initial 18-FDG PET/CT in estrogen receptor positive/Her2 negative (ER+/HER2-) early breast cancer (eBC).
 
Hugo Corda
No Relationships to Disclose
 
Hamza Lasla
No Relationships to Disclose
 
Camille Guillerminet
No Relationships to Disclose
 
Marie Lacombe
Consulting or Advisory Role - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Sylvie Girault
Consulting or Advisory Role - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Mario Campone
Honoraria - Lilly; Novartis
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca/MedImmune (Inst); Daiichi Sankyo Europe GmbH; Diaccurate (Inst); Lilly (Inst); Menarini; Novartis (Inst); PET-THERAPY (Inst); Pfizer; Pierre Fabre (Inst); Sandoz-Novartis (Inst); Sanofi (Inst); Seagen (Inst)
Speakers' Bureau - Amgen; Lilly (Inst); Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Pfizer
Other Relationship - Roche
 
Jean-Sebastien Frenel
Consulting or Advisory Role - Amgen; AstraZeneca (Inst); Clovis Oncology (Inst); Daiichi Sankyo Europe GmbH (Inst); Eisai; Exact Sciences (Inst); Gilead Sciences; GlaxoSmithKline; Lilly; MSD Oncology (Inst); Novartis (Inst); Pfizer; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; seagen
 
Pascal Jézéquel
No Relationships to Disclose
 
Anne Patsouris
Honoraria - Gilead Sciences (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); Gilead Sciences (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Eisai; Eisai; NOVARTIS; Pfizer; Roche